Skip to main content
Premium Trial:

Request an Annual Quote

Focus on the Severe

The US Centers for Disease Control and Prevention will no longer investigate mild cases of COVID-19 that crop up among vaccinated individuals, the New York Times reports.

The agency, it notes, had been monitoring all such breakthrough cases. There have been a reported 10,262 breakthrough cases, though that is widely considered to be an undercount, according to the Times. As they write in a Morbidity and Mortality Weekly report, agency researchers found that 27 percent of breakthrough cases were asymptomatic and 10 percent of patients were hospitalized, though some of those hospitalizations were unrelated to COVID-19

As the Times notes, the findings suggest that vaccines are working as hoped, and the CDC had shifted its focus to the most severe cases. "We have to prioritize what we're doing, and the priority is to understand the cases associated with severe disease," Vanderbilt University School of Medicine's Kathryn Edwards tells it.

The Times reports, though, that the move isn't without criticism as some argue the agency is letting potentially informative data slip away. "What if a variant arises that is less responsive or, Lord forbid, unresponsive to the vaccines?" Washington University in St. Louis' Michael Kinch, tells it. "The way you stop it is good old-fashioned epidemiology, which the CDC has historically done very well. But if you don't see it coming, you can't stop it."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.